Beam Therapeutics
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
5
Funding Rounds
$689.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** R. Li* | - | - | |
| J. Ke*** Jo*** | - | - | |
| Fe** Zh*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca**** Ho | - | - | |
| Jo** Ma******** | - | - | |
| Ka****** Wa*** | - | - | linkedin twitter |
| Kr****** Bu*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ka****** Wa*** | - | - | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company Beam Therapeutics has raised a total of $554m in funding over 5 rounds.
Key Insights:
- Beam Therapeutics Venture round, January 19, 2021: $260m
- Beam Therapeutics Venture round, February 11, 2020: $207m
- Beam Therapeutics Series A round, May 2018: $87m
- Beam Therapeutics Inc. funding round, March 2019: $135m
Beam Therapeutics Venture round, January 19, 2021
$260m
Beam Therapeutics Venture round, February 11, 2020
$207m
Beam Therapeutics Series A round, May 2018
$87m
Beam Therapeutics Inc. funding round, March 2019
$135m
Industries
Beam Therapeutics is active in the following industries:
- Genetics
- Gene therapy
- Cell therapy
- Therapeutics
- Biopharmaceutical
- Biologics
- Technology
- Synthetic biology
- Biology
- Biotechnology
- Healthcare
- Regenerative medicine
- Genomics
- Genome editing
- Synthetic chemistry
- Allogeneic cell therapy
- Genetic engineering
- Immunotherapy
- CAR T-Cell therapy